These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18358509)

  • 21. Prosaposin is an AR-target gene and its neurotrophic domain upregulates AR expression and activity in prostate stromal cells.
    Koochekpour S; Lee TJ; Sun Y; Hu S; Grabowski GA; Liu Z; Garay J
    J Cell Biochem; 2008 Aug; 104(6):2272-85. PubMed ID: 18481277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of a hyperactive androgen receptor leads to androgen-independent growth of prostate cancer cells.
    Hsieh CL; Cai C; Giwa A; Bivins A; Chen SY; Sabry D; Govardhan K; Shemshedini L
    J Mol Endocrinol; 2008 Jul; 41(1):13-23. PubMed ID: 18469090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholesterol level of lipid raft microdomains regulates apoptotic cell death in prostate cancer cells through EGFR-mediated Akt and ERK signal transduction.
    Oh HY; Lee EJ; Yoon S; Chung BH; Cho KS; Hong SJ
    Prostate; 2007 Jul; 67(10):1061-9. PubMed ID: 17469127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell cycle regulator cdk2ap1 inhibits prostate cancer cell growth and modifies androgen-responsive pathway function.
    Zolochevska O; Figueiredo ML
    Prostate; 2009 Oct; 69(14):1586-97. PubMed ID: 19585490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of androgen receptor signaling in prostate cancer by the cochaperone small glutamine rich tetratricopeptide repeat containing protein alpha.
    Buchanan G; Ricciardelli C; Harris JM; Prescott J; Yu ZC; Jia L; Butler LM; Marshall VR; Scher HI; Gerald WL; Coetzee GA; Tilley WD
    Cancer Res; 2007 Oct; 67(20):10087-96. PubMed ID: 17942943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression, regulation and function of the ISGylation system in prostate cancer.
    Kiessling A; Hogrefe C; Erb S; Bobach C; Fuessel S; Wessjohann L; Seliger B
    Oncogene; 2009 Jul; 28(28):2606-20. PubMed ID: 19430494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Androgen receptor regulates CD168 expression and signaling in prostate cancer.
    Lin SL; Chang D; Chiang A; Ying SY
    Carcinogenesis; 2008 Feb; 29(2):282-90. PubMed ID: 18174258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclooxygenase-2 expression is dependent upon epidermal growth factor receptor expression or activation in androgen independent prostate cancer.
    Jia RP; Xu LW; Su Q; Zhao JH; Li WC; Wang F; Xu Z
    Asian J Androl; 2008 Sep; 10(5):758-64. PubMed ID: 18645679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
    Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I
    Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations in the expression of androgen receptor, wild type-epidermal growth factor receptor and a mutant epidermal growth factor receptor in human prostate cancer.
    Olapade-Olaopa EO; Moscatello DK; MacKay EH; Sandhu DP; Terry TR; Wong AJ; Habib FK
    Afr J Med Med Sci; 2004 Sep; 33(3):245-53. PubMed ID: 15819472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies.
    Mimeault M; Batra SK
    Carcinogenesis; 2006 Jan; 27(1):1-22. PubMed ID: 16195239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of mu-crystallin as an androgen-regulated gene in human prostate cancer.
    Malinowska K; Cavarretta IT; Susani M; Wrulich OA; Uberall F; Kenner L; Culig Z
    Prostate; 2009 Jul; 69(10):1109-18. PubMed ID: 19353593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracellular adaptor molecules and AR signalling in the tumour microenvironment.
    Reebye V; Frilling A; Habib NA; Mintz PJ
    Cell Signal; 2011 Jun; 23(6):1017-21. PubMed ID: 21130868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of ETS-like transcription factor 4 as a novel androgen receptor target in prostate cancer cells.
    Makkonen H; Jääskeläinen T; Pitkänen-Arsiola T; Rytinki M; Waltering KK; Mättö M; Visakorpi T; Palvimo JJ
    Oncogene; 2008 Aug; 27(36):4865-76. PubMed ID: 18469865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compartmentalization of EGFR in cellular membranes: role of membrane rafts.
    Balbis A; Posner BI
    J Cell Biochem; 2010 Apr; 109(6):1103-8. PubMed ID: 20143338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgen receptor cytosine-adenine-guanine repeat polymorphisms modulate EGFR signaling in epithelial ovarian carcinomas.
    Li AJ; Scoles DR; Armstrong KU; Karlan BY
    Gynecol Oncol; 2008 May; 109(2):220-5. PubMed ID: 18374401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor.
    Malinowska K; Neuwirt H; Cavarretta IT; Bektic J; Steiner H; Dietrich H; Moser PL; Fuchs D; Hobisch A; Culig Z
    Endocr Relat Cancer; 2009 Mar; 16(1):155-69. PubMed ID: 19011039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
    Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA
    Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential regulation of cell death in head and neck cell carcinoma through alteration of cholesterol levels in lipid rafts microdomains.
    Bionda C; Athias A; Poncet D; Alphonse G; Guezguez A; Gambert P; Rodriguez-Lafrasse C; Ardail D
    Biochem Pharmacol; 2008 Feb; 75(3):761-72. PubMed ID: 17996216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Membrane rafts as potential sites of nongenomic hormonal signaling in prostate cancer.
    Freeman MR; Cinar B; Lu ML
    Trends Endocrinol Metab; 2005 Aug; 16(6):273-9. PubMed ID: 16002302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.